Tag: Cancer: Prostate

Nomogram estimate for individual's risk for nonlocalized disease on prostate-specific membrane antigen PET/CT linked to long-term outcomes

Prostate-specific antigen testing rates increased for men aged 40 to 89 years following 2017 revision of USPSTF recommendation on screening

And standard of care plus abiraterone improves survival in men with metastatic castration-sensitive prostate cancer

Stockholm3 of 0.11 or higher combined with MRI-targeted and systematic biopsies could detect significant cancers, reduce overdetection

Predictors include lower level of education, years since radical prostatectomy, FCR, no current adjuvant therapy, anxiety

PSA level, velocity, and prostate cancer cell growth reduced with HIIT in men with localized prostate cancer under active surveillance

Black men less likely than White men to undergo prostatectomy despite similar COVID-19 risk factors, biopsy Gleason grade groups

MRI with targeted and standard biopsy in those with positive MRI results noninferior to standard biopsy in men with elevated PSA levels

¹⁷⁷Lu-PSMA-617 added to standard care prolonged imaging-based progression-free survival and overall survival

In high treatment benefit category, Black men less likely to receive definitive treatment than non-Black men